Director Dealing

The Company announces that Dr Jim Millen, Chief Executive Officer of Physiomics, has transferred, for no consideration, 242,287 ordinary shares of 0.4p each in the Company (“Ordinary Shares”) from a brokerage account with James Brearley & Sons Limited to an account with Interactive Investors.  The Ordinary Shares remain beneficially owned by Dr Millen.

Dr Millen’s holding in the Company therefore remains 1,384,393 Ordinary Shares, representing approximately 1.42 per cent. of the Company’s issued share capital.

 

Enquiries:

Physiomics plc                                                  

Dr Jim Millen, CEO

+44 (0)1865 784 980

 

Hybridan LLP (broker)

Claire Louise Noyce

+44 (0) 203 764 2341

 

Strand Hanson Ltd (NOMAD)

James Dance & James Bellman

+44 (0)20 7409 3494

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name James Millen
2 Reason for the notification
a) Position/status Director, CEO
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Physiomics plc
b) LEI 213800A71DSZ6ABMTQ91
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

 

Identification code

Ordinary share

 

 

GB00BDR6W943

b) Nature of the transaction Transfer of Ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil 242,287
d) Aggregated information

–        Aggregated volume

–        Price

 

242,287

Nil

e) Date of the transaction 21 May 2021
f) Place of the transaction XLON, AIM